Julia Freise

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

Jürgen Behr, Antje Prasse, Michael Kreuter et al. · The Lancet Respiratory Medicine · 2021 · 490 citations · Full text

Antifibrotic Therapy, Advanced Lung Disease, Idiopathic Pulmonary Fibrosis +6

Chlamydia trachomatis genes whose products are related to energy metabolism are expressed differentially in active vs. persistent infection

Hervé C. Gérard, Julia Freise, Zhao Wang et al. · Microbes and Infection · 2002 · 96 citations

Persistent Infection, Energy Metabolism, Pathogenesis +6

Free-breathing Dynamic ¹⁹F Gas MR Imaging for Mapping of Regional Lung Ventilation in Patients with COPD

Marcel Gutberlet, Till F. Kaireit, Andreas Voskrebenzev et al. · Radiology · 2017 · 66 citations

Late outcomes after acute pulmonary embolism: rationale and design of FOCUS, a prospective observational multicenter cohort study

Stavros Konstantinides, Stefano Barco, Stephan Rosenkranz et al. · Journal of Thrombosis and Thrombolysis · 2016 · 61 citations · Full text

Thrombosis, Pulmonary Embolism, Retrospective Cohort Study +9

Quality of Life 3 and 12 Months Following Acute Pulmonary Embolism

Luca Valerio, Stefano Barco, Marius Jankowski et al. · CHEST Journal · 2021 · 61 citations · Full text